Showing results (101-110 of 460) with videos related to
Sort By:
Pageof 46
British Journal of Clinical Pharmacology|July 18, 2006
Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elementsAndrew Owen, Chris Goldring, Paul Morgan, et al.British Journal of Clinical Pharmacology|September 14, 2017
Renal function monitoring in heart failure - what is the optimal frequency? A narrative reviewAhmed Al-Naher, David Wright, Mark Alexander John Devonald, et al.Current Drug Safety|August 12, 2008
Adverse drug reactions in hospitals: a narrative reviewEmma C Davies, Christophe F Green, David R Mottram, et al.Journal of Clinical and Experimental Hepatology|May 4, 2026
Delineating Metabolic Dysfunction-Associated Steatotic Liver Disease and Comorbid Risk With Clinical, Blood and Metabolomic Parameters-A UK Biobank AnalysisBrian Ho, Yun Xu, Christopher E Goldring, et al.Pediatric Nephrology (Berlin, Germany)|November 17, 2016
Aminoglycoside-induced nephrotoxicity in childrenStephen J McWilliam, Daniel J Antoine, Rosalind L Smyth, et al.BMC Pharmacology & Toxicology|December 19, 2014
Clinical coding of prospectively identified paediatric adverse drug reactions--a retrospective review of patient recordsJennifer R Bellis, Jamie J Kirkham, Anthony J Nunn, et al.British Journal of Clinical Pharmacology|July 21, 2010
Interpreting adverse drug reaction (ADR) reports as hospital patient safety incidentsEmma C Davies, Christopher F Green, David R Mottram, et al.Journal of HIV Therapy|July 3, 2003
Mechanisms of drug hypersensitivity in HIV-infected patients: the role of the immune systemF Javier Vilar, Dean J Naisbitt, B Kevin Park, et al.British Journal of Clinical Pharmacology|July 7, 2015
Social media and pharmacovigilance: A review of the opportunities and challengesRichard Sloane, Orod Osanlou, David Lewis, et al.British Journal of Clinical Pharmacology|October 28, 2019
Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary preventionRichard M Turner, Vanessa Fontana, Richard FitzGerald, et al.Pageof 46